For two decades, the MPN Research Foundation has funded research to advance knowledge towards new treatments for people living with rare blood cancers known as MPNs. Our investments in cutting edge, global, multi-center research has advanced understanding of the causes of MPNs, led to the development of new treatments, and improved the quality of life for MPN patients.
The MPN Research Foundation funded seven new projects from 2019-2021 as part of the Challenge Grant Program. Each grant recipient was awarded $100,000 for research toward new and better treatments, and finding the answers that help clinicians and patients better understand MPNs. New Challenge Grant awardees will be announced later this fall!
Subscribe to our monthly digital digest and printed newsletter for news on MPN research, clinical trials, and community events as well as opportunities to support our efforts.
Engage with us on Facebook, Instagram, LinkedIn and Twitter by following us and tagging us in your posts.
Make a gift today to help fund and advance the most innovative and effective research in MPNs.
We’re glad to partner with the MPN Advocates Network to present a webinar on Changing the Conversation Around MPNs.
This webinar features Dr. Claire Harrison of Guy's and St Thomas' NHS Foundation Trust and Dr. Ruben Mesa of UT Health San Antonio.
MPN Research Foundation 180 N Michigan Avenue Suite 1870 Chicago, IL 60601
The MPN Research Foundation has a single goal: to stimulate original research in pursuit of new treatments — and eventually a cure — for polycythemia vera,essential thrombocythemia and myelofibrosis, known collectively as myeloproliferative neoplasms (MPNs). MPN Research Foundation is a 501(c)3 Nonprofit with tax ID number 36-4330967.
© Copyright 2021. All Rights Reserved. MPN Research Foundation